Fabien Rollot

7PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthMedical mycologyRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 05, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

|Jul 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Antoine Gavoille, Emmanuelle Leray, Romain Marignier

|Jul 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Camille Robin, Fabien Rollot, Mathilde Lefort

|Sep 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study.

Marion Hay, Fabien Rollot, Romain Casey

|Oct 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality.

Fabien Rollot, Zoé Uhry, Emmanuelle Dantony

|Feb 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.

Fabien Rollot, Justine Couturier, Romain Casey

Pageof 2

Frequent Collaborators

5 joint publications

Jean Pelletier

5 joint publications

Pierre Clavelou

5 joint publications

Sandra Vukusic

5 joint publications

David-Axel Laplaud